logo

Fate Therapeutics Inc (FATE) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Fate Therapeutics Inc’s current trading price is -83.12% away from its 52-week high, while its distance from the 52-week low is -3.86%. The stock’s price range over this period has fluctuated between $1.55 and $8.83. The company, operating within the financial sector, had a trading volume of approximately 2.57 million for the day, which was noticeably lower than the average daily share volume of 2.95 million over the last 3 months.

Fate Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $8.83 on 03/07/24 and the lowest value was $1.55 on 01/10/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Fate Therapeutics Inc (FATE) has experienced a quarterly decline of -50.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 169.71M and boasts a workforce of 181 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.8226, with a change in price of -1.9100. Similarly, Fate Therapeutics Inc recorded 2,302,426 in trading volume during the last 100 days, posting a change of -56.18%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.25.

FATE Stock Stochastic Average

Today, Fate Therapeutics Inc’s raw stochastic average for the past 50 days stands at 0.50%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.20%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 7.36% and 11.73% respectively.

FATE Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -9.69% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -56.17%. Over the past 30 days, the price of FATE has leaped by -45.22%. And in the last five days, it has fallen by -16.75%.

Most Popular